Last reviewed · How we verify
Acute myeloblastic leukemia
Approved treatments
- Doxorubicin Hydrochloride · Pfizer Inc.
Doxorubicin intercalates nucleotide bases and interacts with topoisomerase II to form DNA-cleavable complexes, inhibiting DNA/RNA replication.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Acute myeloblastic leukemia patent landscape — cliff calendar, originator estates, attackable patents
- Acute myeloblastic leukemia treatment landscape brief
- Acute myeloblastic leukemia treatment updates RSS
Frequently asked questions about Acute myeloblastic leukemia
What drugs treat Acute myeloblastic leukemia?
Tracked treatments include Doxorubicin Hydrochloride.
What is the treatment for Acute myeloblastic leukemia?
Standard treatment for Acute myeloblastic leukemia includes Doxorubicin Hydrochloride. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Acute myeloblastic leukemia patent cliff · Acute myeloblastic leukemia CI report
- Treatment: Doxorubicin Hydrochloride · Pfizer Inc.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing